Consonance Capital Partners is a New York–based private equity firm investing exclusively in U.S. middle-market healthcare companies. Founded by Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle—who together bring over 90 years of private equity experience, primarily from JPMorgan Partners—CCP has raised more than $1.3 billion in equity capital across two funds and is currently deploying its second fund. The firm targets growth equity, leveraged buyouts, and recapitalizations in companies with $25 million to $500 million in revenue that deliver sustainable value to the healthcare system through higher-quality care at lower cost. CCP's sector focus spans providers, payors, diagnostics, distribution, devices, specialty pharmaceuticals, outsourced services, and healthcare IT. The firm takes a hands-on approach, partnering closely with management teams and leveraging its extensive network to drive organic growth, operational improvements, and M&A.

Profile auto-generated from public sources — details unverified.